Skip to main content

COVID-19 Topic Center

Diabetes Expert Insights

Pharmacy Learning Network
Diabetes is a well-known risk factor for the development of heart failure.1 Pre-diabetes continues to grow in the United States.2 This is important because pre-diabetes associated dysglycemia is associated with abnormal cardiac structure and function, associated with a higher risk of heart failure.…
Pharmacy Learning Network
By Yvette C. Terrie, BS Pharm, RPh, Consultant Pharmacist Metformin is one of the most extensively prescribed drugs used to treat T2DM and is also recommended by the American Diabetes Association (ADA) as the preferred initial pharmacological agent for the treatment of T2DM either alone or in…
Pharmacy Learning Network
By Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd  All of us have experienced various types of acute and chronic pain throughout our lives and, in many cases, we are fortunate to see the pain go away or diminish over time as the body uses…
Pharmacy Learning Network
By: Yvette C. Terrie, RPh, BS Pharm, Consultant Pharmacist, Medical Writer As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes. They can also utilize…
Pharmacy Learning Network
By Julie Gould Julie Lauffenburger, PharmD, Harvard Medical School and division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital, explains how more intensive insulin-adherence interventions impact patient outcomes and highlights the challenges faced when…
Pharmacy Learning Network
A 56-year-old male patient with type 2 diabetes reveals to a hospital pharmacist at discharge that he often takes NyQuil and DayQuil to treat common cold symptoms. What should the pharmacist tell the patient about taking the popular over-the-counter cold medicine? Click here to learn more
Pharmacy Learning Network
The answer may be yes. Diabetes mellitus has reached panepidemic proportions across the world with approximately 382 million people diagnosed and is set to rise to 592 million by 2040.1 In 2013, half of all premature deaths in adults under the age of 60 were attributable to diabetes. Another 175…
Pharmacy Learning Network
Statins along with aspirin and inhibitors of the renin-angiotensin-renin system are foundational to the treatment of atherosclerotic cardiovascular disease. The National Health and Nutrition Examination Study or NHANES reported that in 2011-2012, 23% of adults over the age of 40 reported using a…
Pharmacy Learning Network
In May 2015 the U.S. Food and Drug Administration (FDA) issued a warning that SGLT-2 inhibitors might cause diabetic ketoacidosis. FDA Adverse Event Reporting System (FAERS) database identified 20 cases of acidosis reported as diabetic ketoacidosis (DKA), ketoacidosis, or ketosis in patients…
Pharmacy Learning Network
Now that there are 11 classes of drugs available to treat type 2 diabetes (T2D), many hospital pharmacies are questioning which of these agents should be on the institution formulary for in-patient use. Despite all of the advances in diabetes pharmacotherapy, insulin still remains the gold standard…
Back to Top